Landmark Trial reduces Maternal infections and Deaths by 32%

A landmark multi-country clinical trial has demonstrated that a structured, sustainable approach to infection prevention and treatment can substantially save women’s lives, reducing severe maternal infections and deaths by approximately one-third (32%) compared to standard care. The maternal programme of prevention and treatment (APT-Sepsis) was developed by researchers at the University of Liverpool,the World Health Association (WHO),and the UN’s Special Programme in Human Reproduction (HRP).

The Global Challenge of Maternal Sepsis

Maternal infection and sepsis remain leading causes of maternal death worldwide.Tragically, a mother dies from a sepsis-related cause every 30 minutes somewhere in the world, with the greatest impact felt by women in low- and middle-income countries. This highlights a critical need for effective interventions.

Introducing APT-Sepsis: A Complete Intervention

The Active Prevention and Treatment of Maternal Sepsis (APT-Sepsis) intervention addresses this challenge through an integrated programme focused on three key areas:

• Improving Hand Hygiene: A foundational element in preventing the spread of infection.
• Strengthening Infection Prevention and Management: Implementing robust protocols to minimize risks.
• Enhancing Sepsis Care with the FAST-M Sepsis Bundle: Providing a standardized approach to early recognition and timely treatment.

Trial Results: Notable Impact in Malawi and Uganda

The trial, conducted across 59 hospitals in Malawi and Uganda and involving over 430,000 women, rigorously assessed whether structured improvements in infection prevention, early detection, and prompt treatment of maternal sepsis could demonstrably save lives. The findings are compelling.

Key Findings from the Trial

The study revealed that the APT-Sepsis intervention reduced the incidence of maternal infection-related mortality or severe morbidity by 32%. Importantly,the program proved equally effective in both Uganda and Malawi. The effectiveness wasn’t just immediate; it increased steadily over time, reaching a 47% reduction in the final month of the intervention.

“Even within a very resource-limited habitat, this innovative approach made it possible to support healthcare workers to improve maternal outcomes and can be sustained in resource-limited health systems.”

sustaining Impact and Future Implications

The sustained effectiveness of the APT-sepsis program is notably noteworthy. It demonstrates that improvements in maternal care are achievable and maintainable even in challenging healthcare settings. This is crucial for long-term impact.

Key Takeaways

• A 32% reduction in maternal infection-related mortality or severe morbidity was observed.
• The intervention was effective in both Uganda and Malawi.
• Effectiveness increased over time, reaching 47% in the final month.
• The program is sustainable in resource-limited health systems.

Looking Ahead

These findings represent a significant step forward in global maternal health. The APT-Sepsis program offers a scalable and sustainable solution to reduce maternal deaths from infection. Future efforts will focus on expanding the program to other countries and integrating it into existing healthcare systems to maximize its impact and ensure that more women receive the care they deserve.